PHE Paper Selected As Value in Health Editor's Choice Article

We are proud to announce that a recently published paper with PHE co-authors, “Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations,” has been selected to be an Editors’ Choice article in the June 2017 issue of Value in Health.

To see the complete article as it appears online, please click here.

FEATURED NEWS

Restricting access based upon ICER estimates: value should not be one-size-fits-all

By: Jason Shafrin, PhD Sr. Director, Policy and Economics and Jacki Chou, MPL Senior Director, Policy and Economics The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the heterogeneity in patient clinical needs and preferences.

PHE Paper Selected As Value in Health Editor's Choice Article

FEATURED NEWS

Restricting access based upon ICER estimates: value should not be one-size-fits-all

RELATED ITEMS

HCEI Guidance Should Ease Specialty Drug Management

Precision Value & Health Listed in MM&Ms Top 100 Agencies

PHE's Snider Presents New CAR T-cell Study at ASCO: CAR T-cell Therapy Benefit Dependent on Prompt Treatment

PM360 Names Dan Renick as Elite Award Winner

The Appeal of Value Assessment at ISPOR 2018

RECENT NEWS

Did you miss PHE’s exclusive live webinar: Lessons Learned from the Oncology Care Model Implementation? Don’t worry—you can catch up on-demand!

PHE in Vaccine: New Policy Study Examines Universal Purchase (UP) Programs

Open-Source Tools for Value Assessment